Group A (N = 36) | Group B (N = 38) | Group A vs. B p-value | Group C (N = 34) | Group B vs. C p-value | |
---|---|---|---|---|---|
Concomitant procedure, n (%) | 1(2.8) | 0 | 0.30 | 0 | |
Op time (min) | 114.9 ± 29.1 | 96.1 ± 13.5 | < 0.001* | 92.1 ± 12.1 | 0.20 |
LOS (days) | 2.9 ± 0.8 | 2.2 ± 0.5 | < 0.001* | 2.2 ± 0.4 | 0.70 |
Conversion | 0 | 0 | 0 | ||
30-day complications, n (%) | 1 (2.8) | 1 (2.6) | 0.97 | 1 (2.9) | 0.62 |
Stenosis | 1 | 0 | 0 | ||
Melena | 0 | 0 | 1 | ||
Hematemesis | 0 | 1 | 0 | ||
30-day ER visit, n (%) | 0 | 2 (5.3) | 0.16 | 1 (2.9) | 0.62 |
30-day readmission, n (%) | 1 (2.8) | 1 (2.6) | 0.97 | 0 | 0.34 |
30-day mortality, n (%) | 0 | 0 | 0 | ||
1-year follow-up, n (%) | 30(83)% | 30(79)% | 28(82)% | ||
%EWL | 76.4 ± 18.2 | 80.6 ± 19.8 | 0.40 | 82.4 ± 14.3 | 0.70 |
%TWL | 26.7 ± 5.1 | 25.1 ± 6.6 | 0.28 | 28.0 ± 5.4 | 0.07 |